ES2201567T3 - Nuevo metodo de clonacion de dna basado en el sistema de recombinacion rece-rect de e. coli. - Google Patents
Nuevo metodo de clonacion de dna basado en el sistema de recombinacion rece-rect de e. coli.Info
- Publication number
- ES2201567T3 ES2201567T3 ES98963541T ES98963541T ES2201567T3 ES 2201567 T3 ES2201567 T3 ES 2201567T3 ES 98963541 T ES98963541 T ES 98963541T ES 98963541 T ES98963541 T ES 98963541T ES 2201567 T3 ES2201567 T3 ES 2201567T3
- Authority
- ES
- Spain
- Prior art keywords
- dna
- host cell
- molecule
- dna molecule
- rece
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000010367 cloning Methods 0.000 title claims abstract description 123
- 238000000034 method Methods 0.000 title claims abstract description 81
- 230000006798 recombination Effects 0.000 title claims abstract description 67
- 238000005215 recombination Methods 0.000 title claims abstract description 66
- 108020004414 DNA Proteins 0.000 claims abstract description 190
- 210000004027 cell Anatomy 0.000 claims abstract description 120
- 102000053602 DNA Human genes 0.000 claims abstract description 92
- 101100355997 Bacillus subtilis (strain 168) recA gene Proteins 0.000 claims abstract description 47
- 101100301301 Escherichia coli (strain K12) recE gene Proteins 0.000 claims abstract description 47
- 230000006801 homologous recombination Effects 0.000 claims abstract description 47
- 238000002744 homologous recombination Methods 0.000 claims abstract description 47
- 101100356230 Escherichia coli (strain K12) recT gene Proteins 0.000 claims abstract description 46
- 230000007246 mechanism Effects 0.000 claims abstract description 17
- 108020004638 Circular DNA Proteins 0.000 claims abstract description 16
- 230000001419 dependent effect Effects 0.000 claims abstract description 16
- 238000012986 modification Methods 0.000 claims abstract description 9
- 230000004048 modification Effects 0.000 claims abstract description 9
- 210000001236 prokaryotic cell Anatomy 0.000 claims abstract description 6
- 230000003362 replicative effect Effects 0.000 claims abstract description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 144
- 241000588724 Escherichia coli Species 0.000 claims description 57
- 239000013598 vector Substances 0.000 claims description 56
- 150000007523 nucleic acids Chemical class 0.000 claims description 52
- 230000014509 gene expression Effects 0.000 claims description 41
- 239000013612 plasmid Substances 0.000 claims description 33
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 30
- 239000003550 marker Substances 0.000 claims description 28
- 102000004169 proteins and genes Human genes 0.000 claims description 27
- 102000039446 nucleic acids Human genes 0.000 claims description 24
- 108020004707 nucleic acids Proteins 0.000 claims description 24
- 230000001580 bacterial effect Effects 0.000 claims description 22
- 238000006243 chemical reaction Methods 0.000 claims description 19
- 108010052160 Site-specific recombinase Proteins 0.000 claims description 15
- 239000003153 chemical reaction reagent Substances 0.000 claims description 15
- 230000009466 transformation Effects 0.000 claims description 14
- 239000003112 inhibitor Substances 0.000 claims description 13
- 210000000349 chromosome Anatomy 0.000 claims description 12
- 108010091086 Recombinases Proteins 0.000 claims description 11
- 102000018120 Recombinases Human genes 0.000 claims description 11
- 239000003999 initiator Substances 0.000 claims description 11
- 239000002773 nucleotide Substances 0.000 claims description 10
- 125000003729 nucleotide group Chemical group 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 9
- 101150061231 recE gene Proteins 0.000 claims description 8
- 230000010076 replication Effects 0.000 claims description 8
- 101150087770 recT gene Proteins 0.000 claims description 7
- 108020004511 Recombinant DNA Proteins 0.000 claims description 6
- 230000002068 genetic effect Effects 0.000 claims description 6
- 229920001184 polypeptide Polymers 0.000 claims description 6
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 6
- 239000013611 chromosomal DNA Substances 0.000 claims description 5
- 238000004520 electroporation Methods 0.000 claims description 5
- 108700008625 Reporter Genes Proteins 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 4
- 108091092566 Extrachromosomal DNA Proteins 0.000 claims description 3
- 230000003385 bacteriostatic effect Effects 0.000 claims description 3
- 230000007812 deficiency Effects 0.000 claims description 3
- 231100000331 toxic Toxicity 0.000 claims description 3
- 230000002588 toxic effect Effects 0.000 claims description 3
- 239000003242 anti bacterial agent Substances 0.000 claims description 2
- 230000008030 elimination Effects 0.000 claims description 2
- 238000003379 elimination reaction Methods 0.000 claims description 2
- 238000011426 transformation method Methods 0.000 claims description 2
- 235000019687 Lamb Nutrition 0.000 claims 3
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- 239000000047 product Substances 0.000 description 90
- 239000012634 fragment Substances 0.000 description 53
- 230000035772 mutation Effects 0.000 description 21
- 229930027917 kanamycin Natural products 0.000 description 20
- 229960000318 kanamycin Drugs 0.000 description 20
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 20
- 229930182823 kanamycin A Natural products 0.000 description 20
- 101150066555 lacZ gene Proteins 0.000 description 18
- 150000001413 amino acids Chemical class 0.000 description 17
- 229960000723 ampicillin Drugs 0.000 description 14
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 14
- 229960005091 chloramphenicol Drugs 0.000 description 14
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 14
- 241001045988 Neogene Species 0.000 description 13
- 101150091879 neo gene Proteins 0.000 description 13
- 102000005936 beta-Galactosidase Human genes 0.000 description 12
- 108010005774 beta-Galactosidase Proteins 0.000 description 12
- 108091034117 Oligonucleotide Proteins 0.000 description 11
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 10
- 101100288095 Klebsiella pneumoniae neo gene Proteins 0.000 description 9
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 9
- 230000003115 biocidal effect Effects 0.000 description 9
- 238000012217 deletion Methods 0.000 description 9
- 230000037430 deletion Effects 0.000 description 9
- 230000008859 change Effects 0.000 description 8
- 238000000338 in vitro Methods 0.000 description 8
- 238000003780 insertion Methods 0.000 description 8
- 230000037431 insertion Effects 0.000 description 8
- 108060002716 Exonuclease Proteins 0.000 description 7
- 101100125257 Mus musculus Hoxa3 gene Proteins 0.000 description 7
- 229930006000 Sucrose Natural products 0.000 description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 7
- 230000000295 complement effect Effects 0.000 description 7
- 230000029087 digestion Effects 0.000 description 7
- 102000013165 exonuclease Human genes 0.000 description 7
- 230000006698 induction Effects 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 101150079601 recA gene Proteins 0.000 description 7
- 108091008146 restriction endonucleases Proteins 0.000 description 7
- 238000010187 selection method Methods 0.000 description 7
- 239000005720 sucrose Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000004098 Tetracycline Substances 0.000 description 6
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 6
- 238000003306 harvesting Methods 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 229960002180 tetracycline Drugs 0.000 description 6
- 229930101283 tetracycline Natural products 0.000 description 6
- 235000019364 tetracycline Nutrition 0.000 description 6
- 150000003522 tetracyclines Chemical class 0.000 description 6
- 241001515965 unidentified phage Species 0.000 description 6
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 5
- 238000002105 Southern blotting Methods 0.000 description 5
- 101150044616 araC gene Proteins 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 230000010354 integration Effects 0.000 description 5
- 230000001404 mediated effect Effects 0.000 description 5
- 101150025220 sacB gene Proteins 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 125000003275 alpha amino acid group Chemical group 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 239000013613 expression plasmid Substances 0.000 description 4
- 230000037361 pathway Effects 0.000 description 4
- 230000001052 transient effect Effects 0.000 description 4
- 101100002068 Bacillus subtilis (strain 168) araR gene Proteins 0.000 description 3
- 108020004705 Codon Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 108010046276 FLP recombinase Proteins 0.000 description 3
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 101100309436 Streptococcus mutans serotype c (strain ATCC 700610 / UA159) ftf gene Proteins 0.000 description 3
- 206010042602 Supraventricular extrasystoles Diseases 0.000 description 3
- 101150102092 ccdB gene Proteins 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 101150034785 gamma gene Proteins 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 208000024191 minimally invasive lung adenocarcinoma Diseases 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 230000013819 transposition, DNA-mediated Effects 0.000 description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- 108010051219 Cre recombinase Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- DGMPVYSXXIOGJY-UHFFFAOYSA-N Fusaric acid Chemical compound CCCCC1=CC=C(C(O)=O)N=C1 DGMPVYSXXIOGJY-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010040925 Skin striae Diseases 0.000 description 2
- 208000031439 Striae Distensae Diseases 0.000 description 2
- 108010020764 Transposases Proteins 0.000 description 2
- 102000008579 Transposases Human genes 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 108700003859 araC Genes Proteins 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 101150049515 bla gene Proteins 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- FGDZQCVHDSGLHJ-UHFFFAOYSA-M rubidium chloride Chemical compound [Cl-].[Rb+] FGDZQCVHDSGLHJ-UHFFFAOYSA-M 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 101100402795 Caenorhabditis elegans mtl-1 gene Proteins 0.000 description 1
- BQENDLAVTKRQMS-SBBGFIFASA-L Carbenoxolone sodium Chemical compound [Na+].[Na+].C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C([O-])=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](OC(=O)CCC([O-])=O)C1(C)C BQENDLAVTKRQMS-SBBGFIFASA-L 0.000 description 1
- 238000011537 Coomassie blue staining Methods 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 238000012270 DNA recombination Methods 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- QTANTQQOYSUMLC-UHFFFAOYSA-O Ethidium cation Chemical compound C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 QTANTQQOYSUMLC-UHFFFAOYSA-O 0.000 description 1
- 102000008338 G protein-coupled adenosine receptor activity proteins Human genes 0.000 description 1
- 108040002766 G protein-coupled adenosine receptor activity proteins Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 108091029795 Intergenic region Proteins 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 229910021586 Nickel(II) chloride Inorganic materials 0.000 description 1
- 108091060545 Nonsense suppressor Proteins 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 102000001218 Rec A Recombinases Human genes 0.000 description 1
- 108010055016 Rec A Recombinases Proteins 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000701835 Salmonella virus P22 Species 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 101100478714 Streptomyces griseus strR gene Proteins 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000029918 bioluminescence Effects 0.000 description 1
- 238000005415 bioluminescence Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 230000002153 concerted effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 230000037433 frameshift Effects 0.000 description 1
- 238000002825 functional assay Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 101150055782 gH gene Proteins 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 108091008053 gene clusters Proteins 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000006799 invasive growth in response to glucose limitation Effects 0.000 description 1
- 101150062200 lacC gene Proteins 0.000 description 1
- 101150018339 lacS gene Proteins 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 230000000869 mutational effect Effects 0.000 description 1
- QMMRZOWCJAIUJA-UHFFFAOYSA-L nickel dichloride Chemical compound Cl[Ni]Cl QMMRZOWCJAIUJA-UHFFFAOYSA-L 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000013615 primer Substances 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 101150070367 recC gene Proteins 0.000 description 1
- 101150002589 recF gene Proteins 0.000 description 1
- 101150056906 recJ gene Proteins 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229940102127 rubidium chloride Drugs 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000017105 transposition Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Mycology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97121462 | 1997-12-05 | ||
| EP97121462 | 1997-12-05 | ||
| EP98118756 | 1998-10-05 | ||
| EP98118756 | 1998-10-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2201567T3 true ES2201567T3 (es) | 2004-03-16 |
Family
ID=26145961
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES98963541T Expired - Lifetime ES2201567T3 (es) | 1997-12-05 | 1998-12-07 | Nuevo metodo de clonacion de dna basado en el sistema de recombinacion rece-rect de e. coli. |
| ES02021915T Expired - Lifetime ES2337027T3 (es) | 1997-12-05 | 1998-12-07 | Nuevo metodo de clonacion de dna basado en el sistema de recombinacion rece-rect de e. coli. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES02021915T Expired - Lifetime ES2337027T3 (es) | 1997-12-05 | 1998-12-07 | Nuevo metodo de clonacion de dna basado en el sistema de recombinacion rece-rect de e. coli. |
Country Status (11)
| Country | Link |
|---|---|
| US (5) | US6509156B1 (https=) |
| EP (2) | EP1034260B1 (https=) |
| JP (1) | JP4139561B2 (https=) |
| AT (2) | ATE449844T1 (https=) |
| AU (1) | AU752105B2 (https=) |
| CA (2) | CA2759882A1 (https=) |
| DE (2) | DE69815384T2 (https=) |
| DK (1) | DK1034260T3 (https=) |
| ES (2) | ES2201567T3 (https=) |
| PT (1) | PT1034260E (https=) |
| WO (1) | WO1999029837A2 (https=) |
Families Citing this family (109)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6156574A (en) | 1997-06-23 | 2000-12-05 | The Rockefeller University | Methods of performing gene trapping in bacterial and bacteriophage-derived artificial chromosomes and use thereof |
| US6821759B1 (en) | 1997-06-23 | 2004-11-23 | The Rockefeller University | Methods of performing homologous recombination based modification of nucleic acids in recombination deficient cells and use of the modified nucleic acid products thereof |
| EP1025217B1 (en) * | 1997-10-24 | 2006-10-04 | Invitrogen Corporation | Recombinational cloning using nucleic acids having recombination sites |
| US6509156B1 (en) * | 1997-12-05 | 2003-01-21 | Europaisches Laboratorium Fur Molekularoiologie (Embl) | DNA cloning method relying on the E. coli recE/recT recombination system |
| AUPP684998A0 (en) * | 1998-10-30 | 1998-11-26 | Murdoch Institute for Research into Birth Defects Limited, The | A method of recombination and agents useful for same |
| US6720139B1 (en) | 1999-01-27 | 2004-04-13 | Elitra Pharmaceuticals, Inc. | Genes identified as required for proliferation in Escherichia coli |
| US6709852B1 (en) | 1999-06-22 | 2004-03-23 | Invitrogen Corporation | Rapid growing microorganisms for biotechnology applications |
| CN1192101C (zh) * | 1999-06-25 | 2005-03-09 | 惠氏控股有限公司 | 革兰阴性菌的肽聚糖结合脂蛋白的脂化形式的制备 |
| US6355412B1 (en) * | 1999-07-09 | 2002-03-12 | The European Molecular Biology Laboratory | Methods and compositions for directed cloning and subcloning using homologous recombination |
| AU6229800A (en) * | 1999-07-20 | 2001-02-05 | Rockefeller University, The | Conditional homologous recombination of large genomic vector inserts |
| US6589738B1 (en) | 1999-11-09 | 2003-07-08 | Elitra Pharmaceuticals, Inc. | Genes essential for microbial proliferation and antisense thereto |
| DK1311661T3 (da) | 2000-08-14 | 2012-11-26 | Us Gov Health & Human Serv | Forøget homolog rekombination medieret ved lambda-rekombinationsproteiner |
| US7198924B2 (en) | 2000-12-11 | 2007-04-03 | Invitrogen Corporation | Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites |
| WO2002062988A2 (en) * | 2001-02-09 | 2002-08-15 | Gene Bridges Gmbh | Recombination method |
| US20020165175A1 (en) * | 2001-04-17 | 2002-11-07 | Xiaowu Liang | Fast and enzymeless cloning of nucleic acid fragments |
| EP1409702A1 (en) * | 2001-07-20 | 2004-04-21 | Youming Zhang | Improved rect or recet cloning and subcloning method |
| WO2003010333A2 (en) * | 2001-07-24 | 2003-02-06 | Affinium Pharmaceuticals Inc. | Methods for gene disruption and uses thereof |
| US7338800B2 (en) * | 2002-01-16 | 2008-03-04 | Baylor College Of Medicine | In vivo gene transfer |
| CA2473741C (en) * | 2002-01-18 | 2015-12-22 | Morphotek, Inc. | A method for generating engineered cells for locus specific gene regulation and analysis |
| US20060270043A1 (en) * | 2002-01-23 | 2006-11-30 | Blattner Frederick R | Bacteria with reduced genome |
| US8765408B2 (en) | 2002-01-23 | 2014-07-01 | Wisconsin Alumni Research Foundation | Prophage element-free bacteria |
| US8039243B2 (en) * | 2002-01-23 | 2011-10-18 | Wisconsin Alumni Research Foundation | Insertion sequence-free bacteria |
| US6989265B2 (en) * | 2002-01-23 | 2006-01-24 | Wisconsin Alumni Research Foundation | Bacteria with reduced genome |
| US8119365B2 (en) * | 2002-01-23 | 2012-02-21 | Wisconsin Alumni Research Foundation | Insertion sequence-free bacteria |
| WO2003089587A2 (en) * | 2002-04-16 | 2003-10-30 | Promega Corporation | Method to enhance homologous recombination |
| AU2003257155A1 (en) * | 2002-08-02 | 2004-02-23 | The General Hospital Corporation | Methods for the production of cells and mammals with desired genetic modifications |
| DE10236001A1 (de) | 2002-08-06 | 2004-02-19 | Icon Genetics Ag | Transformation von Plastiden unter Verwendung modularer Vektoren |
| US7303906B2 (en) * | 2002-09-06 | 2007-12-04 | Wisconsin Alumni Research Foundation | Competent bacteria |
| US7563600B2 (en) * | 2002-09-12 | 2009-07-21 | Combimatrix Corporation | Microarray synthesis and assembly of gene-length polynucleotides |
| US20040209370A1 (en) * | 2002-12-19 | 2004-10-21 | Wonchul Suh | Method for chromosomal engineering |
| US7521242B2 (en) | 2003-05-09 | 2009-04-21 | The United States Of America As Represented By The Department Of Health And Human Services | Host cells deficient for mismatch repair and their use in methods for inducing homologous recombination using single-stranded nucleic acids |
| WO2005014796A2 (en) | 2003-08-08 | 2005-02-17 | Invitrogen Corporation | Methods and compositions for seamless cloning of nucleic acid molecules |
| WO2005054438A2 (en) * | 2003-12-01 | 2005-06-16 | Invitrogen Corporation | Nucleic acid molecules containing recombination sites and methods of using the same |
| AU2005222788A1 (en) * | 2004-02-27 | 2005-09-29 | President And Fellows Of Harvard College | Polynucleotide synthesis |
| JP2005245320A (ja) * | 2004-03-04 | 2005-09-15 | Aisin Seiki Co Ltd | 核酸組換え方法、宿主細胞、及び、発現ベクター |
| US7674621B2 (en) | 2004-05-21 | 2010-03-09 | The United States Of America As Represented By The Department Of Health And Human Services | Plasmids and phages for homologous recombination and methods of use |
| US20070122817A1 (en) * | 2005-02-28 | 2007-05-31 | George Church | Methods for assembly of high fidelity synthetic polynucleotides |
| JP2008523786A (ja) * | 2004-10-18 | 2008-07-10 | コドン デバイシズ インコーポレイテッド | 高忠実度合成ポリヌクレオチドのアセンブリ方法 |
| GB0423755D0 (en) * | 2004-10-26 | 2004-11-24 | Gene Bridges Gmbh | Methods for heterologus expression of secondary metabolites |
| US20080051326A1 (en) * | 2004-11-12 | 2008-02-28 | Alexander Dylan C | Antiinfective Lipopeptides |
| WO2006127423A2 (en) * | 2005-05-18 | 2006-11-30 | Codon Devices, Inc. | Methods of producing polynucleotide libraries using scarless ligation |
| WO2007005053A1 (en) * | 2005-06-30 | 2007-01-11 | Codon Devices, Inc. | Hierarchical assembly methods for genome engineering |
| WO2007110695A2 (en) * | 2005-10-13 | 2007-10-04 | Bc Cancer Agency | Modular genomes for synthetic biology and metabolic engineering |
| KR100681815B1 (ko) | 2005-12-02 | 2007-02-12 | 한국생명공학연구원 | 리컴비네이즈 매개 선택표지 유전자 발현유도에 의한 목표유전자 간편 클로닝 및 목표 단백질 신속 발현 방법. |
| WO2007136834A2 (en) * | 2006-05-19 | 2007-11-29 | Codon Devices, Inc. | Combined extension and ligation for nucleic acid assembly |
| ES2465996T3 (es) * | 2006-05-25 | 2014-06-09 | Sangamo Biosciences, Inc. | Métodos y composiciones para la inactivación genética |
| US8053191B2 (en) | 2006-08-31 | 2011-11-08 | Westend Asset Clearinghouse Company, Llc | Iterative nucleic acid assembly using activation of vector-encoded traits |
| WO2008142028A1 (en) | 2007-05-17 | 2008-11-27 | Boehringer Ingelheim Rcv Gmbh & Co Kg | Method for producing a recombinant protein on a manufacturing scale |
| GB0803109D0 (en) * | 2008-02-20 | 2008-03-26 | Gene Bridges Gmbh | Method of nucleic acid recombination |
| EP2251423B1 (en) | 2008-03-07 | 2016-01-13 | National University Corporation University Of Toyama | Homologous recombination method, cloning method, and kit |
| WO2010030776A1 (en) * | 2008-09-10 | 2010-03-18 | Genscript Corporation | Homologous recombination-based dna cloning methods and compositions |
| GB0909660D0 (en) | 2009-06-04 | 2009-07-22 | Gene Bridges Gmbh | Method of altering nucleic acids |
| DK3622815T3 (da) | 2009-07-08 | 2023-06-26 | Kymab Ltd | Gnavermodeller og terapeutiske molekyler |
| WO2011053957A2 (en) | 2009-11-02 | 2011-05-05 | Gen9, Inc. | Compositions and methods for the regulation of multiple genes of interest in a cell |
| US20110125118A1 (en) * | 2009-11-20 | 2011-05-26 | Opx Biotechnologies, Inc. | Production of an Organic Acid and/or Related Chemicals |
| GB0922108D0 (en) | 2009-12-17 | 2010-02-03 | Gene Bridges Gmbh | Heterologous hosts |
| WO2011080505A2 (en) | 2009-12-28 | 2011-07-07 | Bigdna Ltd | Method of growing phage for commercial use |
| JP2011217736A (ja) * | 2010-03-26 | 2011-11-04 | Aichi Medical Univ | 組換えクラミジア及びその製造方法 |
| US9096825B2 (en) | 2010-05-27 | 2015-08-04 | Pharmazell Gmbh | 7 α-hydroxysteroid dehydrogenase knockout mutants and use therefor |
| GB201009732D0 (en) | 2010-06-10 | 2010-07-21 | Gene Bridges Gmbh | Direct cloning |
| CN103228130B (zh) | 2010-06-17 | 2016-03-16 | 科马布有限公司 | 动物模型及治疗分子 |
| WO2012064975A1 (en) | 2010-11-12 | 2012-05-18 | Gen9, Inc. | Protein arrays and methods of using and making the same |
| CN103502448B (zh) | 2010-11-12 | 2017-03-29 | Gen9股份有限公司 | 核酸合成的方法和设备 |
| CA2868113A1 (en) | 2011-03-22 | 2012-09-27 | Opx Biotechnologies, Inc. | Microbial production of chemical products and related compositions, methods and systems |
| LT2944693T (lt) | 2011-08-26 | 2019-08-26 | Gen9, Inc. | Kompozicijos ir būdai, skirti nukleorūgščių didelio tikslumo sąrankai |
| BR112014006394A2 (pt) | 2011-09-19 | 2017-03-28 | Kymab Ltd | manipulação de diversidade genética de imunoglobulina e terapêuticos multi-anticorpos |
| US12595500B2 (en) | 2011-09-26 | 2026-04-07 | Life Technologies Corporation | High efficiency, small volume nucleic acid synthesis |
| CN107058059B (zh) | 2011-09-26 | 2020-08-07 | 基因技术股份公司 | 高效的小体积核酸合成 |
| WO2014153188A2 (en) | 2013-03-14 | 2014-09-25 | Life Technologies Corporation | High efficiency, small volume nucleic acid synthesis |
| US9253965B2 (en) | 2012-03-28 | 2016-02-09 | Kymab Limited | Animal models and therapeutic molecules |
| CN103160495A (zh) * | 2011-12-15 | 2013-06-19 | 张力军 | 一种非连接依赖性的快速克隆方法 |
| US9150853B2 (en) | 2012-03-21 | 2015-10-06 | Gen9, Inc. | Methods for screening proteins using DNA encoded chemical libraries as templates for enzyme catalysis |
| CN102634534A (zh) * | 2012-03-30 | 2012-08-15 | 深圳市中联生物科技开发有限公司 | 基于同源重组的核酸分子克隆方法及相关试剂盒 |
| CA2871505C (en) | 2012-04-24 | 2021-10-12 | Gen9, Inc. | Methods for sorting nucleic acids and multiplexed preparative in vitro cloning |
| US20130288320A1 (en) | 2012-04-27 | 2013-10-31 | Bioamber Inc. | Methods and microorganisms for increasing the biological synthesis of difunctional alkanes |
| CN102676470B (zh) * | 2012-05-29 | 2014-04-16 | 吴江近岸蛋白质科技有限公司 | 一种用于快速基因克隆的酶混合物及制备方法、包含该酶混合物的试剂盒 |
| IL236303B (en) | 2012-06-25 | 2022-07-01 | Gen9 Inc | Methods for high-throughput nucleic acid assembly and sequencing |
| US20150353940A1 (en) * | 2013-08-05 | 2015-12-10 | Absci, Llc | Vectors for use in an inducible coexpression system |
| MX2015001780A (es) | 2012-08-10 | 2015-09-28 | Opx Biotechnologies Inc | Microorganismos y métodos para la producción de ácidos grasos y productos derivados de ácidos grasos. |
| SI2959006T1 (sl) | 2013-02-22 | 2018-10-30 | F. Hoffmann-La Roche Ag | Uporaba prokariontskega seva, ozdravljenega aminokislinske avksotrofije, za proizvodnjo rekombinantnega polipeptida |
| US20150119601A1 (en) | 2013-03-15 | 2015-04-30 | Opx Biotechnologies, Inc. | Monofunctional mcr + 3-hp dehydrogenase |
| US11408013B2 (en) | 2013-07-19 | 2022-08-09 | Cargill, Incorporated | Microorganisms and methods for the production of fatty acids and fatty acid derived products |
| EP3022310B1 (en) | 2013-07-19 | 2019-10-16 | Cargill, Incorporated | Microorganisms and methods for the production of fatty acids and fatty acid derived products |
| AU2015324564B2 (en) | 2014-06-11 | 2021-07-01 | Duke University | Compositions and methods for rapid and dynamic flux control using synthetic metabolic valves |
| EP2993228B1 (en) | 2014-09-02 | 2019-10-09 | Cargill, Incorporated | Production of fatty acid esters |
| US10407676B2 (en) | 2014-12-09 | 2019-09-10 | Life Technologies Corporation | High efficiency, small volume nucleic acid synthesis |
| CN104630178A (zh) * | 2015-01-28 | 2015-05-20 | 苏州神洲基因有限公司 | 一种混合蛋白酶体系、包含该混合蛋白酶体系的试剂盒及其使用方法 |
| BR112017021667A2 (pt) | 2015-04-09 | 2018-07-24 | Genomatica Inc | microorganismos modificados & métodos para produção aperfeiçoada de álcool de crotila |
| US11345938B2 (en) | 2017-02-02 | 2022-05-31 | Cargill, Incorporated | Genetically modified cells that produce C6-C10 fatty acid derivatives |
| JP2020530979A (ja) | 2017-06-30 | 2020-11-05 | インスクリプタ， インコーポレイテッド | 自動細胞処理方法、モジュール、機器及びシステム |
| US10738327B2 (en) | 2017-08-28 | 2020-08-11 | Inscripta, Inc. | Electroporation cuvettes for automation |
| JP6985508B2 (ja) | 2017-09-30 | 2021-12-22 | インスクリプタ， インコーポレイテッド | フロースルーエレクトロポレーション機器編成 |
| US10443031B1 (en) | 2018-03-29 | 2019-10-15 | Inscripta, Inc. | Methods for controlling the growth of prokaryotic and eukaryotic cells |
| WO2019200004A1 (en) | 2018-04-13 | 2019-10-17 | Inscripta, Inc. | Automated cell processing instruments comprising reagent cartridges |
| WO2019209926A1 (en) | 2018-04-24 | 2019-10-31 | Inscripta, Inc. | Automated instrumentation for production of peptide libraries |
| US10557216B2 (en) | 2018-04-24 | 2020-02-11 | Inscripta, Inc. | Automated instrumentation for production of T-cell receptor peptide libraries |
| US10858761B2 (en) | 2018-04-24 | 2020-12-08 | Inscripta, Inc. | Nucleic acid-guided editing of exogenous polynucleotides in heterologous cells |
| CA3108767A1 (en) | 2018-06-30 | 2020-01-02 | Inscripta, Inc. | Instruments, modules, and methods for improved detection of edited sequences in live cells |
| US10532324B1 (en) | 2018-08-14 | 2020-01-14 | Inscripta, Inc. | Instruments, modules, and methods for improved detection of edited sequences in live cells |
| US11142740B2 (en) | 2018-08-14 | 2021-10-12 | Inscripta, Inc. | Detection of nuclease edited sequences in automated modules and instruments |
| WO2020081149A2 (en) | 2018-08-30 | 2020-04-23 | Inscripta, Inc. | Improved detection of nuclease edited sequences in automated modules and instruments |
| US20220228157A1 (en) * | 2019-05-23 | 2022-07-21 | President And Fellows Of Harvard College | Gene editing in diverse bacteria |
| WO2020257395A1 (en) | 2019-06-21 | 2020-12-24 | Inscripta, Inc. | Genome-wide rationally-designed mutations leading to enhanced lysine production in e. coli |
| US10927385B2 (en) | 2019-06-25 | 2021-02-23 | Inscripta, Inc. | Increased nucleic-acid guided cell editing in yeast |
| US10689669B1 (en) | 2020-01-11 | 2020-06-23 | Inscripta, Inc. | Automated multi-module cell processing methods, instruments, and systems |
| BR112022017196A2 (pt) * | 2020-03-03 | 2022-10-25 | Univ Leland Stanford Junior | Recombinação genômica guiada por rna na escala de kilobase |
| US20210332388A1 (en) | 2020-04-24 | 2021-10-28 | Inscripta, Inc. | Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells |
| US11787841B2 (en) | 2020-05-19 | 2023-10-17 | Inscripta, Inc. | Rationally-designed mutations to the thrA gene for enhanced lysine production in E. coli |
| CN115160416B (zh) * | 2022-06-08 | 2025-06-10 | 青岛农业大学 | 一种感应潜艇金属离子Cd(II)的AraC突变体及其构建的探潜微生物传感器和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4963487A (en) * | 1985-01-03 | 1990-10-16 | Massachusetts Institute Of Technology | Method for deletion of a gene from a bacteria |
| US5286632A (en) * | 1991-01-09 | 1994-02-15 | Jones Douglas H | Method for in vivo recombination and mutagenesis |
| US5605793A (en) * | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| US6509156B1 (en) * | 1997-12-05 | 2003-01-21 | Europaisches Laboratorium Fur Molekularoiologie (Embl) | DNA cloning method relying on the E. coli recE/recT recombination system |
-
1998
- 1998-12-07 US US09/555,510 patent/US6509156B1/en not_active Expired - Lifetime
- 1998-12-07 WO PCT/EP1998/007945 patent/WO1999029837A2/en not_active Ceased
- 1998-12-07 PT PT98963541T patent/PT1034260E/pt unknown
- 1998-12-07 CA CA2759882A patent/CA2759882A1/en not_active Abandoned
- 1998-12-07 AT AT02021915T patent/ATE449844T1/de not_active IP Right Cessation
- 1998-12-07 JP JP2000524410A patent/JP4139561B2/ja not_active Expired - Lifetime
- 1998-12-07 AU AU18771/99A patent/AU752105B2/en not_active Expired
- 1998-12-07 ES ES98963541T patent/ES2201567T3/es not_active Expired - Lifetime
- 1998-12-07 EP EP98963541A patent/EP1034260B1/en not_active Expired - Lifetime
- 1998-12-07 DE DE69815384T patent/DE69815384T2/de not_active Expired - Lifetime
- 1998-12-07 CA CA2312474A patent/CA2312474C/en not_active Expired - Lifetime
- 1998-12-07 EP EP02021915A patent/EP1291420B1/en not_active Expired - Lifetime
- 1998-12-07 ES ES02021915T patent/ES2337027T3/es not_active Expired - Lifetime
- 1998-12-07 DK DK98963541T patent/DK1034260T3/da active
- 1998-12-07 DE DE69841340T patent/DE69841340D1/de not_active Expired - Lifetime
- 1998-12-07 AT AT98963541T patent/ATE242320T1/de active
-
2002
- 2002-08-30 US US10/231,013 patent/US6787316B2/en not_active Expired - Lifetime
-
2004
- 2004-05-11 US US10/842,534 patent/US7736851B2/en not_active Expired - Fee Related
-
2010
- 2010-04-09 US US12/757,129 patent/US20100317061A1/en not_active Abandoned
-
2012
- 2012-01-03 US US13/342,621 patent/US20120208277A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20030036198A1 (en) | 2003-02-20 |
| EP1034260B1 (en) | 2003-06-04 |
| EP1034260A2 (en) | 2000-09-13 |
| US20120208277A1 (en) | 2012-08-16 |
| AU1877199A (en) | 1999-06-28 |
| WO1999029837A3 (en) | 1999-07-22 |
| ATE449844T1 (de) | 2009-12-15 |
| US20040203057A1 (en) | 2004-10-14 |
| US20100317061A1 (en) | 2010-12-16 |
| DE69815384D1 (de) | 2003-07-10 |
| AU752105B2 (en) | 2002-09-05 |
| US7736851B2 (en) | 2010-06-15 |
| CA2759882A1 (en) | 1999-06-17 |
| EP1291420B1 (en) | 2009-11-25 |
| JP4139561B2 (ja) | 2008-08-27 |
| WO1999029837B1 (en) | 1999-09-16 |
| PT1034260E (pt) | 2003-10-31 |
| WO1999029837A2 (en) | 1999-06-17 |
| ES2337027T3 (es) | 2010-04-20 |
| US6509156B1 (en) | 2003-01-21 |
| CA2312474A1 (en) | 1999-06-17 |
| ATE242320T1 (de) | 2003-06-15 |
| DK1034260T3 (da) | 2003-09-29 |
| CA2312474C (en) | 2012-07-03 |
| EP1291420A1 (en) | 2003-03-12 |
| DE69815384T2 (de) | 2003-12-04 |
| DE69841340D1 (de) | 2010-01-07 |
| US6787316B2 (en) | 2004-09-07 |
| JP2002503448A (ja) | 2002-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2201567T3 (es) | Nuevo metodo de clonacion de dna basado en el sistema de recombinacion rece-rect de e. coli. | |
| Wang et al. | An improved recombineering approach by adding RecA to λ red recombination | |
| ES3019688T3 (en) | Methods and compositions for modifying a targeted locus | |
| EP1311661B1 (en) | Enhanced homologous recombination mediated by lambda recombination proteins | |
| Court et al. | Mini-λ: a tractable system for chromosome and BAC engineering | |
| JP2021166513A (ja) | 配列操作のためのＣＲＩＳＰＲ−Ｃａｓ成分系、方法および組成物 | |
| US20200370035A1 (en) | Methods for in vitro site-directed mutagenesis using gene editing technologies | |
| US7074611B2 (en) | Method for the stable inversion of DNA sequence by site-specific recombination and DNA vectors and transgenic cells thereof | |
| KR20180012834A (ko) | 두 개의 벡터로부터 발현된 Cas9 단백질을 이용한 유전자 발현 조절 방법 | |
| AU2001283377A1 (en) | Enhanced homologous recombination mediated by lambda recombination proteins | |
| JP2005517447A (ja) | Ｔｎ５結合Ｃｒｅ／ｌｏｘＰ切除システムによる最小化ゲノムを含む新規菌株の構築 | |
| Muyrers et al. | ET-cloning: think recombination first | |
| CN111699254A (zh) | 使用crispr在棒状杆菌属中进行基因组编辑 | |
| Liu et al. | [32] Rapid construction of recombinant DNA by the univector plasmid-fusion system | |
| US20050079618A1 (en) | Host cells deficient for mismatch repair and their use in methods for inducing homologous recombination using single-stranded nucleic acids | |
| US20050260585A1 (en) | Poison/antidote genetic systems for the selection of genetically modified eucaryote cells or organisms | |
| CN101812442A (zh) | 一种寡核苷酸介导的大肠杆菌基因敲除或点突变的方法 | |
| WO2002044415A1 (en) | Method for screening of dna libraries and generation of recombinant dna constructs | |
| AU2002313350B2 (en) | Novel DNA cloning method | |
| ES2923629T3 (es) | Métodos para la introducción sin cicatrices de modificaciones dirigidas en vectores de direccionamiento | |
| JP2021164447A (ja) | ゲノム改変方法及びゲノム改変キット | |
| HK1051705A (en) | Novel dna cloning method relying on the e.coli rece/rect recombination system | |
| US20030082723A1 (en) | Use of mutated recognition sequences for multiple consecutive recombinase-mediated recombinations in a genetic system | |
| WO2023060351A1 (en) | Genetic engineering with deinococcus radiodurans | |
| Bhatt et al. | Targeted DNA transposition using a dCas9-transposase fusion protein |